Literature DB >> 2274448

Anatomic evidence of spontaneous intrauterine closure of a ventricular septal defect.

A Nir1, Z Weintraub, A Oliven, J Kelener, M Lurie.   

Abstract

An infant, born to a mother on carbamazepine monotherapy, had a complex cardiac anomaly, consisting of double-outlet right ventricle (DORV), right-sided aorta, pulmonary artery hypoplasia, left ventricular endocardial fibroelastosis, and anatomic evidence of a spontaneously closed muscular ventricular septal defect (VSD). The last finding is one which, to the best of our knowledge, has never been illustrated before.

Entities:  

Mesh:

Year:  1990        PMID: 2274448     DOI: 10.1007/BF02238368

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  6 in total

Review 1.  Natural history of congenital heart disease. Problems in its assessment with special reference to ventricular septal defects.

Authors:  J I Hoffman
Journal:  Circulation       Date:  1968-01       Impact factor: 29.690

Review 2.  Spontaneous closure of ventricular septal defects. Anatomic evidence in six adult patients.

Authors:  H Suzuki
Journal:  Am J Clin Pathol       Date:  1969-10       Impact factor: 2.493

3.  The distribution of fibrosis in the left ventricle in congenital aortic stenosis and coarctation of the aorta.

Authors:  M D Cheitlin; M Robinowitz; H McAllister; J I Hoffman; S Bharati; M Lev
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

4.  Anatomic evidence for spontaneous closure of ventricular septal defect.

Authors:  R L Simmons; J H Moller; J E Edwards
Journal:  Circulation       Date:  1966-07       Impact factor: 29.690

5.  Spontaneous closure of small ventricular septal defects: ten-year follow-up.

Authors:  B S Alpert; D H Cook; P J Varghese; R D Rowe
Journal:  Pediatrics       Date:  1979-02       Impact factor: 7.124

6.  Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan.

Authors:  Y Nakane; T Okuma; R Takahashi; Y Sato; T Wada; T Sato; Y Fukushima; H Kumashiro; T Ono; T Takahashi; Y Aoki; H Kazamatsuri; M Inami; S Komai; M Seino; M Miyakoshi; T Tanimura; H Hazama; R Kawahara; S Otsuki; K Hosokawa; K Inanaga; Y Nakazawa; K Yamamoto
Journal:  Epilepsia       Date:  1980-12       Impact factor: 5.864

  6 in total
  8 in total

1.  Spontaneous closure of ventricular septal defects.

Authors:  P R Rao
Journal:  Pediatr Cardiol       Date:  1992-07       Impact factor: 1.655

2.  Intrauterine closure of ventricular septal defects.

Authors:  A Nir
Journal:  Pediatr Cardiol       Date:  1993-01       Impact factor: 1.655

Review 3.  A review of isolated muscular ventricular septal defect.

Authors:  Toshiharu Miyake
Journal:  World J Pediatr       Date:  2019-07-25       Impact factor: 2.764

Review 4.  A review of spontaneous closure of ventricular septal defect.

Authors:  Jun Zhang; Jong Mi Ko; Joseph M Guileyardo; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

5.  Intrauterine closure of membranous ventricular septal defects: mechanism of closure in two autopsy specimens.

Authors:  A Nir; D J Driscoll; W D Edwards
Journal:  Pediatr Cardiol       Date:  1994 Jan-Feb       Impact factor: 1.655

6.  Prediction of spontaneous closure of ventricular septal defect and guidance for clinical follow-up.

Authors:  Xinyang Li; Weidong Ren; Guang Song; Xintong Zhang
Journal:  Clin Cardiol       Date:  2019-03-25       Impact factor: 2.882

7.  Prediction of spontaneous closure of isolated ventricular septal defects in utero and postnatal life.

Authors:  Xing Li; Gui-Xian Song; Li-Jie Wu; Yu-Mei Chen; Yi Fan; Yun Wu; Ya-Hui Shen; Li Cao; Ling-Mei Qian
Journal:  BMC Pediatr       Date:  2016-12-08       Impact factor: 2.125

8.  A case of hypertrophic cardiomyopathy combined with muscular ventricular septal defect and abnormal origin of right coronary artery.

Authors:  Guang-Mei Zheng; Jiao Bai; Jun-Ming Tang; Fang-Cheng Zhu; Hong-Xia Jing
Journal:  BMC Cardiovasc Disord       Date:  2019-01-14       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.